saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemic - Ónæmisbælandi lyf - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
cinacalcet stada filmuhúðuð tafla 90 mg
stada arzneimittel ag - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 90 mg
cinacalcet stada filmuhúðuð tafla 60 mg
stada arzneimittel ag - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 60 mg
sildenafil medical valley filmuhúðuð tafla 100 mg
medical valley invest ab - sildenafilum cítrat - filmuhúðuð tafla - 100 mg
cinacalcet stada filmuhúðuð tafla 30 mg
stada arzneimittel ag - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 30 mg
imodium filmuhúðuð tafla 2 mg
mcneil sweden ab - loperamidum hýdróklóríð - filmuhúðuð tafla - 2 mg
metoprolol alvogen (metoprolin) tafla 100 mg
alvogen ehf. - metoprololum tartrat - tafla - 100 mg
metoprolol alvogen (metoprolin) tafla 50 mg
alvogen ehf. - metoprololum tartrat - tafla - 50 mg
sildenafil medical valley filmuhúðuð tafla 50 mg
medical valley invest ab - sildenafilum cítrat - filmuhúðuð tafla - 50 mg
zassida stungulyfsstofn, dreifa 25 mg/ml
zentiva k.s.* - azacitidinum inn - stungulyfsstofn, dreifa - 25 mg/ml